NCT06463873

Study of OmniGraft in Simultaneous Pancreas Kidney Recipients

A Pilot Study of OmniGraft in Simultaneous Pancreas Kidney Recipients

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 40 (actual)
• Sponsor: University of Miami · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this research is learn about how OmniGraf works in kidney pancreas transplant patients. Also, to analyze the performance characteristics of OmniGrafTM (TruGraf Gene Expression Profiling (GEP) and T Cell Receptor Alpha Constant (TRAC) dd-cfDNA) in a population of simultaneous kidney pancreas transplants as a part of routine surveillance, as well as a part of the workup for patients clinically suspected to have rejection of the kidney and/or pancreas.

Conditions

• Kidney Transplant; Complications
• Pancreas Disease

Timeline

• Start date: 2024-07-01
• Primary completion: 2025-02-11
• Completion: 2025-02-11
• First posted: 2024-06-18
• Last updated: 2025-02-27

Locations

2 sites across 1 country: United States